Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-23-010202

Options or other derivatives

  • See Remarks acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Galletta Christopher See Remarks 2023-02-16 Grant or award · Stock Option (right to buy) +40,000 40,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…